FEB 18, 2020 8:29 AM PST

Newly Found Glycopeptide Antibiotics Kill Bacteria in a New Way

WRITTEN BY: Carmen Leitch

The overuse and misuse of antibiotics and the adaptability of microbes has created a problem that people must solve: common antibiotics are not as effective as they used to be. Researchers have to engineer new drugs to fight microbial pathogens that are posing a growing threat to public health. Scientists have now identified two antibiotic compounds that attack bacteria in a new way and make good candidates for new medicines. The findings have been reported in Nature.

A medical illustration of methicillin-resistant, Staphylococcus aureus (MRSA) bacteria / Credit: CDC / Antibiotic Resistance Coordination and Strategy Unit / Medical Illustrator: Meredith Newlove

The investigators have found that two molecules in the glycopeptide antibiotic family, called corbomycin and complestatin, interfere with cell wall function in bacteria. These antibiotics are produced by microbes that live in soil. In a mouse model, the researchers showed that the drugs work against Staphylococcus aureus infections that are drug-resistant, known as MRSA. MRSA infections can be life-threatening in people.

"Bacteria have a wall around the outside of their cells that gives them shape and is a source of strength," said study first author Beth Culp, a graduate candidate in biochemistry and biomedical sciences at McMaster University.

"Antibiotics like penicillin kill bacteria by preventing building of the wall, but the antibiotics that we found actually work by doing the opposite; they prevent the wall from being broken down. This is critical for cell to divide," Culp explained. "In order for a cell to grow, it has to divide and expand. If you completely block the breakdown of the wall, it is like it is trapped in a prison, and can't expand or grow."

The researchers focused on molecules that are known to be part of the glycopeptide family. Next, they analyzed the genes carried by those members that don't have known resistance mechanisms, looking for a glycopeptide that might have a different strategy for killing bacteria.

"We hypothesized that if the genes that made these antibiotics were different, maybe the way they killed the bacteria was also different," added Culp.

Using sophisticated imaging tools, the researchers were able to confirm that the antibiotics they found work on the bacterial cell wall.

"This approach can be applied to other antibiotics and help us discover new ones with different mechanisms of action," said Culp. "We found one completely new antibiotic in this study, but since then, we've found a few others in the same family that have this same new mechanism."

Sources: Science Daily via McMaster University, Nature

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 30, 2020
Genetics & Genomics
JAN 30, 2020
Genetically Engineered Bacteria Can Protect Bees From Pathogens
As pollinators, honey bees play a critical role in food production, and they have been suffering heavy losses for years....
FEB 03, 2020
Drug Discovery & Development
FEB 03, 2020
HIV Viral Structures Improve Therapeutics
Researchers have recently discovered how a powerful class of HIV drugs bind to a key piece of HIV machinery. Their findings, for the first time, shows how ...
FEB 10, 2020
Microbiology
FEB 10, 2020
As Ebola Outbreak Continues, Researchers Create Faster Genetic Test
Since 2013, around 30,000 people have been infected during several outbreaks of Ebola in eight different countries....
FEB 08, 2020
Drug Discovery & Development
FEB 08, 2020
Drug Targets Brain-Eating Amoebas
Brain-eating amoebas lead to high rates of mortality as a result of encephalitis. In fact, more than 95% of people who develop the infection will die. Unfo...
MAR 05, 2020
Microbiology
MAR 05, 2020
Researchers Learn How Gut Microbes Can Promote Heart Disease
The microbes in our gastrointestinal tract, collectively known as the gut microbiome, have a powerful impact on our health and well-being....
APR 01, 2020
Clinical & Molecular DX
APR 01, 2020
One dollar kit diagnoses COVID-19 in 10 minutes
Researchers have begun efficacy testing for a new SARS-CoV-2 diagnostic kit that claims to be able to test for COVID-19 infection in just 10 minutes. In th...
Loading Comments...